Company: NAYA Biosciences
Ticker: Nasdaq: NAYA
Sector: Healthcare
Investor Contact: Robert Blum

NAYA Biosciences News

News

INVO Bioscience Reports 2020 Financial Results

Company to Host Conference Call on March 30 at 4:30pm ET (Details Below)SARASOTA, Fla., March 30, 2021 -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers...

INVO Bioscience to Participate in the 33rd Annual Roth Conference

SARASOTA, Fla., March 11, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with...

INVO Bioscience Management Letter to Shareholders

Key Developments and Future Initiatives Position INVOcell® Within the Severely Underserved Fertility MarketSARASOTA, Fla., Jan. 7, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO) ("Company") ('INVO"), a medical device company focused on commercializing the world's...

Skip to content